Rheumatology has been fortunate to have researchers in both basic science and clinical outcomes research over a quarter of a century. Understanding inflammatory joint disease and connective tissue disease including Rheumatoid Arthritis and Systemic Lupus has been a primary focus. Dr. M. Fritzler has been a world leader on research on auto antibodies and in particular, we are proud of his lead article in Nature on the golgi apparatus.
We have a number of successful outcomes researchers as well as a strong Clinical Trials Program. Recently, our focus has been to get the right people to the right place at the right time. This has led to the development with CHAPS (Centre for Health and Policy Studies) of a Priority Referral Score Program. We are particularly proud of our central triage program which has successfully triaged 18,000+ patients to date since 2004.
Within the McCaig Institute, we see our leading role in improving patient outcomes through a strong Clinical Trials Program which is unique in rheumatology within the musculoskeletal discipline as well as timing of the impetus for new models of care and their evaluation. We are particularly fortunate to have a strong Allied Health Team consisting of physiotherapists, nurse practitioners, nurses and social workers.
Through this appointment, Dr. Marshall will develop a world-class rheumatology program in Alberta, with translational research focusing on clinical and health outcomes research, promote interdisciplinary care and collaborative research ultimately promoting the liaison between rheumatology and related research. She will work to attract students, fellows, research associates and faculty interested in rheumatology and act as the spokesperson for the Arthur JE Child Foundation.
Dr. Marshall is a health systems economist with research interests including economic evaluation of health care programmes using decision analysis methodologies, testing and treatment interventions in personalized medicine, methods for measuring patient preferences in the evaluation of medical interventions, and health technology assessment, particularly health system evaluation using operations research methods such as system dynamics modeling in musculoskeletal disease and cancer. She is an Associate Professor in the Department of Community Health Sciences, Director of Health Technology Assessment at the Alberta Bone and Joint Health Institute and a Tier II Canada Research Chair in health services and systems research.
Congratulations Dr. Marshall!
The Institute draws on the financial support of many partners, and thanks to your donation, we are creating new hope not only for Albertans, but for people worldwide. We invite you to consider how you can help effect real change for bone and joint health.
Three of the McCaig Institute’s top researchers and mentors were honoured tonight in a special ceremony by the Arthritis Society. Dr. Cy Frank, Dr. Dianne Mosher and Dr. John Matyas were all presented Queen’s Diamond Jubilee Medals for their outstanding …
Juvenile arthritis (JA) is one of the more common disorders resulting in chronic disability in children and adolescents in Canada. JA can be defined as continuous inflammation (pain, stiffness and swelling) of one or more joints lasting at least six …